Background-The Human papillomavirus (HPV) vaccine has been available for protection against HPV-associated cervical cancer and genital warts since 2006. Nonetheless, uptake has varied among countries and populations within countries. Studies have found that individuals' knowledge and attitudes toward the vaccine are associated with immunization uptake. The purpose of the current review is to summarize and evaluate the evidence for educational interventions to increase HPV vaccination acceptance.
the effectiveness of different message frames in an educational intervention among adolescents, young adults or their parents. Most studies involved populations with higher educational attainment and most interventions required participants to be literate. The minority of studies used the outcome of HPV vaccine uptake. Well-designed studies adequately powered to detect change in vaccine uptake were rare and generally did not demonstrate effectiveness of the tested intervention.
Background
Human papillomavirus (HPV) is among the most common sexually transmitted infections with a global prevalence of 11-12% among women and with rates as high as 16-24% in some regions including sub-Saharan Africa, Eastern Europe and Latin America [1] . It is also the causative agent of nearly all cervical cancer, the second most common cancer in women worldwide [2] . Currently, there are two HPV vaccines that confer protection against HPVassociated cervical cancer, as well as other anogenital cancers. The bivalent Cervarix ® vaccine protects against HPV types 16 and 18 which cause roughly 70% of all cervical cancer [3] . The quadrivalent vaccine, Gardasil ® protects against types 16 and 18 as well as types 6 and 11 which cause more than 90% of genital warts in men and women [4] . In 2006 the U.S. was the first country to approve the quadrivalent vaccine for females, extending this approval to use in males in 2009. The bivalent vaccine was approved for females in the U.S. in 2009 and was licensed in other countries in Europe as well as Australia and the Philippines prior to 2009 [5] . Both vaccines are recommended for use as a 3-dose series over 6 months before the onset of sexual activity and typically starting between ages 10 to 13 years [6, 7] .
According to the World Health Organization's monitoring system, HPV vaccine had been introduced in 57 countries by 2013 [8] . Overall, countries that have school-based vaccination programs, such as Australia, Great Britain and Portugal, have achieved the highest (80% or greater) female vaccination coverage rates [9] , though Denmark has reached very high vaccination rates (3-dose coverage of over 80%) through administration by general practitioners [10] . Studies conducted in countries with national HPV immunization programs have demonstrated clear benefits of mass vaccination in terms of reductions in viral prevalence and associated disease burden. For instance, a recently published study from Australia found lower rates of high-grade cervical abnormalities and high-grade cytology among vaccinated women versus unvaccinated women (hazard ratio 0.72; 95% confidence interval (CI) = 0.58-0.91) [11] . Further Australian data, collected during the first 5 years of their national immunization program, found that the incidence of genital warts decreased more than 50% among females under 30 and more than 70% in heterosexual males of the same age [12] . Similarly, incidence data from Denmark shows that genital warts have declined an average of 3.1% every year since 2007 [10] . In the US, vaccine-type HPV prevalence decreased over 50% among females ages 14-19 years in the first 4 years post-licensure [13] . The vaccine is also safe; there have been no post-marketing surveillance reports of severe side effects [8, [14] [15] [16] [17] .
Despite an excellent safety and efficacy profile, HPV vaccine uptake has varied between countries and between populations within countries. This is the case in Europe as well as among low and middle income countries that have universal vaccination programs [7] . Among high income countries with low coverage rates are France (28.5% for the full 3-dose series) and the United States. (34% for full coverage) [7, 16] . A recent systematic review of studies mostly conducted in the U.S. examining correlates of HPV vaccine uptake in teenage girls identified the following personal cognitive factors: having higher vaccine-related knowledge, having a healthcare provider as a source of information and maintaining positive vaccine attitudes [9] . Therefore, interventions that improve understanding of, and positive attitudes toward HPV vaccine may increase HPV vaccination coverage. Previous successful behavioral interventions to increase compliance with other preventive health recommendations such as increasing sun protection behavior [18] , improving dental hygiene [19] , and increasing adherence to cervical and breast cancer screenings [20] , for example, have employed various education delivery methods, including classroom lectures for adolescents [18] , brief online education for parents [19] , and home visits for women [20] . In our present systematic review, we focus on published evaluations of educational interventions designed to increase HPV vaccine acceptance in patients eligible to receive the vaccine, or their parents."
Methods

Search strategies
We searched both the PubMed and Web of Science databases to ensure comprehensive capture of both the medical and social sciences literature (Web of Science having greater coverage of the social sciences than PubMed). We entered relevant MeSH (Medical Subject Headings) keywords (papillomavirus vaccines and decision making, behavioral research, intervention studies, communication, education or attitude to health) and limited the search by English language. Realizing that some studies were conducted prior to licensure of the HPV vaccine, we searched the maximum date coverage range available in PubMed at the time the search was conducted. Abstracts of all articles with a publication date between 1946 to August 20, 2013 were reviewed for relevance to the study topic. Full-text articles were obtained for studies pertaining to the evaluation of educational interventions to increase HPV vaccination attitudes, intentions or uptake. Two authors independently reviewed the articles to determine relevance for inclusion. In addition, the references of retrieved papers and a recent systematic review of parental vaccine hesitancy interventions [21, 22] were searched for studies that might have been missed in the original search strategy.
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Inclusion and exclusion criteria
We included trials that employed both randomized and nonrandomized designs, as well as quasi-experimental designs (i.e., comparing pre-and post-intervention outcomes). Educational interventions designed to improve patient or parental knowledge or attitudes, and which measured the following outcomes were included: (1) receipt of HPV vaccine (any dose or completion of the 3-dose series), (2) intention to receive HPV vaccine, or (3) attitude toward HPV vaccine. Non-English articles and conference abstracts were excluded. In addition, pilot or descriptive projects which reported only qualitative or anecdotal results were also excluded. Finally, studies that did not focus primarily on populations eligible to receive HPV vaccine or their parents or that did not subset results in a way that we were able to extract information on these target groups were also excluded.
Data extraction
A form was created and used to extract data from all articles to ensure a standardized process was applied. The elements included in the data extraction form were adapted from the GRADEprofiler evidence profile tool for creating Cochrane Reviews Summary of Findings tables and assessing the quality of the evidence. All items captured are reflected in the data presented in Tables 1-5 [23] . Two reviewers independently extracted data from each article and forms were reviewed jointly afterward to achieve consensus.
Data analysis
Studied interventions were too heterogeneous to perform meta-analysis and outcomes were reported in many different ways. To standardize reported outcomes as much as possible and thereby enhance the reader's ability to compare effects across studies, reviewers calculated the relative risk (RR) and 95% confidence interval (CI) whenever sufficient data were provided, and outcomes involved a comparison of event probabilities. When response categories for HPV acceptance survey items included undecided/no response and no, these two categories were combined into a single category for comparison to yes responses. Generated RR and 95%CI are reported for post-intervention responses in tables along with the authors' stated results as they appeared in the original articles. Some studies reported multiple outcomes. In such cases, we reported them in the following hierarchy: receipt of HPV vaccine in preference to intention to receive HPV vaccine in preference to attitude toward HPV vaccine. Our preferences for this hierarchy of outcomes were based on our understanding that intention to vaccinate is an approximation of vaccination behavior, while positive attitude is generally considered a precursor to intention [24] .
If studies reported both between-and within-group comparisons, we preferentially reported between-group comparisons. If studies reported participant intention to receive the HPV vaccine free of cost or for a fee, we reported the outcomes for the free-of-cost vaccine since this removed the confounding factor of financial barriers. If studies included subgroup analysis or interaction terms between the intervention and other variables, we preferentially reported outcomes for the overall groups and main effects of the intervention, respectively.
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Critical appraisal
Each article was evaluated for risk of bias based on the methods suggested by the Cochrane Collaboration [25] including: condition allocation strategy, concealment of condition assignment to participants, research staff blinding, and inclusion of intent to treat analysis. Because the Cochrane criteria support evaluation of clinical trials, we omitted two other appraisal categories as not applicable to this review: loss to follow up (since the vast majority of included studies were conducted in one sitting) and confounding (since there is no consensus regarding which participant factors and theoretical constructs are highly associated with vaccination behavior) [9] . Beyond the Cochrane criteria, we included four additional appraisal categories to meet the objectives of this review: adequate reporting of participant eligibility criteria (e.g., exclusion of participants with prior HPV vaccination), inclusion of a no-treatment or standard-treatment control condition, adequate reporting of interventional and outcome details for the primary research question, and outcome assessment at any point beyond immediately post-intervention. Appraisal of each category and of an overall risk of bias rating (low, medium or high) for each article was performed by two reviewers. Any discrepancy in risk-of-bias rating was discussed to achieve consensus.
Results
Study characteristics
Our search resulted in a total of 33 relevant articles included in this review (Fig. 1 ). Studies were classified into the following categories: parental education (7 studies), adolescent/ young adult education (8 studies) and comparative message persuasiveness (18 studies). If the primary aim of a study was to evaluate the impact of a single educational intervention, compare different delivery modes for the same educational content (e.g., video vs. written information) or the "dose response" (i.e., differential effect of increasing the quantity, length of exposure or extent of education) of two or more educational interventions, the study was categorized as either adolescent/young adult or parental education as appropriate. If the primary aim of a study was to determine the differential effect of two or more interventions with essentially the same educational content but varying message frames, tones or messengers, the study was considered to be in the realm of comparative message persuasiveness.
Critical appraisal
In terms of risk of bias, we judged seven studies to be of low risk, fifteen of medium risk and eleven of high risk (Table 1) . While the majority of included studies were randomized trials, most did not specify whether group assignment was concealed to participants or study personnel and did not include a standard-treatment or no-treatment control group. Most studies did not evaluate interventions with the preferred outcome, HPV vaccination receipt, but rather a proxy of acceptance (intent or attitude). Over half (55%) of the studies did not adequately report interventional and outcome details for the primary research question. Specifically, these studies lacked sufficient descriptions of: their survey measurement scales' items or scoring, the educational content of their interventions, the main effects or significance levels of their outcomes, and the numbers of participants allocated to initial treatment conditions and/or completing protocol. Vaccine. Author manuscript; available in PMC 2015 April 07.
Parental education
We identified seven articles that tested interventions to educate parents of minors in the recommended age range for HPV vaccination ( The format for five of the parental educational interventions was written information fact sheets from 1 to 2 pages in length [26] [27] [28] 30, 31] . Although some of the studies provided more detailed descriptions of the content of the fact sheets given to participants, all provided information on aspects of the potential morbidity associated with HPV infection and informed parents of the current or future availability of an HPV vaccine to protect children against infection. Of the studies examining the effectiveness of parental information sheets, the two that were randomized, controlled trials [27, 28] found no difference in HPV vaccination intention between the experimental and control conditions. The three studies that exclusively compared HPV vaccination intention pre-to post-intervention found a significant increase in intention to vaccinate in parents after they had read the information sheet with risk ratios (RR) and 95% confidence intervals (CI) ranging from 1. Just two studies examined the effects of parental educational interventions that were not fact-sheet based. Spleen et al. tested the effectiveness of a 1-h slide presentation about HPV infection to parents of girls in Appalachian Pennsylvania. This study found increases in scores for intention to accept the HPV vaccine after the presentation of less than 1 point on a 4 point-scale (P = 0.002) although it should be noted that 31% of the sampled parents had daughters who had already started the HPV vaccination series at the time of the intervention [29] . A study by Kepkaet al.
[32] tested the effectiveness of a Spanish-language radio advertisement (referred to as radionovela in the study) to educate Latino parents about HPV vaccination. This study did not find any difference in intention to vaccinate one's daughter's between the experimental and control conditions, (RR = 0.86 (95%CI 0.65-1.13)), although it may have been under-powered as it enrolled only 60 participants.
Adolescent/young adult education
Our search strategy yielded eight educational studies which targeted adolescents or young adults ( Of note, three studies were randomized controlled trials that used the preferred outcome of vaccination behavior [34, 37, 39] . The outcome of interest in two of the three studies was receipt of the first dose of HPV vaccine. The first of these studies was conducted by Patel, et al. and tracked HPV vaccine uptake via medical record review up to 6 months after the intervention [39] . For this intervention, college-aged women were given a written fact sheet, discussed the contents with the study coordinator and received a second copy in the mail two weeks later. The comparator group received a different HPV vaccination fact sheet ("with similar content") once with no reminder mailing and no review of the content. Rate of receipt of the first dose of HPV vaccine in the intervention group was low (5.5%) and did not differ significantly from that of the control group. The other study was conducted by Gottvall et al. and tested the impact of an hour-long lesson on HPV and condom usage for high school students with handouts and online resources [34] . The comparator groups in this study did not receive any education on these topics. Rate of self-reported receipt of the first dose of HPV vaccine in the intervention group was also low (16%) and not significantly different from that of the control groups [34, 39] . Vanderpool et al. conducted a trial comparing completion rates of the 3-dose HPV vaccination series among young women who received the first dose from study personnel [37] . In this study, the difference between the intervention and control conditions was viewing a 13-min video about HPV or not. Both conditions received a CDC-produced HPV vaccine fact sheet and a t-shirt. The authors report 11% more participants in the intervention versus control group received all 3 doses of HPV vaccine within 9 months as assessed via medical record review (RR = 1.36; 95%CI = 1.03-1.79) [37] .
The remaining studies of adolescent and young adult education assessed effects on behavioral intention or attitudes rather than actual vaccination behavior. Four of the five studies were randomized, controlled trials [33,36,38,40]. All five found significant improvement by their chosen measure as assessed immediately post-intervention. However, only one of these studies re-assessed outcome 1 month later, and it found no significant difference between intervention and control groups at follow up [38].
Comparative message persuasiveness
We identified eighteen articles with interventions that tested how the framing of messages about the HPV vaccination influenced vaccine acceptance [41-58] ( Researchers took a variety of approaches to framing the HPV vaccination message including comparing: (1) gain-(advantages of getting vaccinated) versus loss-(disadvantages of not getting vaccinated) framed messages; (2) different delivery formats (e.g., narrative versus informative presentation styles, color priming with red versus gray, and graphic versus nongraphic presentation of HPV infection risk statistics); and (3) different message content foci (cervical cancer versus genital warts prevention) ( Table 5 ).
The most common message-framing model tested was gain versus loss framing with nine studies represented. Sixteen studies in this category examined the effect of message framing on HPV vaccination intention only and none of these studies assessed outcomes beyond immediately postintervention [41-50,53-58]. We here highlight the two message framing trials that used the preferred outcome of interest, HPV vaccine uptake [51, 52] . Both of these studies assessed vaccination receipt by participant self-report 2 months after the intervention. In a large study by Hopfer et al., female college students in the experimental condition viewed brief videos with a narrative message delivered by different source types: peers, medical experts and combined peers and medical experts [51] . Compared with the control group, only the combined peer-expert group reported statistically higher vaccination rates. The effect size was relatively large with participants in the combined peer-expert group twice as likely to report having been vaccinated. The other study to use self-reported HPV vaccination as the outcome of interest included a smaller sample. It involved 75 female college students with half reading a fact sheet explaining the benefits of HPV vaccine for cervical cancer prevention only and the other half reading a fact sheet explaining the benefits for prevention of cervical cancer and genital warts [52] . This study did not find a statistically significant difference between the two groups in immunization rates.
Discussion
We identified 33 studies of HPV vaccination educational interventions: 7 tested the effectiveness of interventions with parents, 8 with adolescents or young adults and 18 compared the effectiveness of different message frames. Unfortunately, our review did not identify any clearly superior interventions meriting strong recommendation for wide-spread implementation. Well-designed studies adequately powered to detect change in vaccine uptake were rare and generally did not demonstrate effectiveness of the tested intervention.
In comparing the outcomes of the randomized trials of educational interventions for adolescents and young adults versus parents, it seems that adolescents' and young adults' intention to receive HPV vaccination may be more readily influenced by educational interventions. In fact, all five of the adolescent/young adult education studies examining effect on vaccination intention or attitude found significant improvement as assessed immediately post-intervention regardless of the format and content of the education. This is in contrast to none of the three randomized trials targeting parents. Perhaps the difference is due in part to the study setting: most of the studies involving adolescents and young adults occurred at school or university where students may have been already primed for learning. Nonetheless, even among adolescents and young adults, there is no evidence that the positive intentions and attitudes achieved by HPV educational interventions are durable or that they impact vaccine uptake. In the only adolescent/young adult education study to include a follow-up assessment, higher intention to be vaccinated seen immediately postintervention was extinguished after 1 month [38] . Furthermore, the two educational trials involving adolescents/young adults that used receipt of the first dose of HPV vaccine as the primary outcome found no significant increase in uptake as a result of their interventions Vaccine. Author manuscript; available in PMC 2015 April 07.
[34,39]. Since virtually all of the interventions were completed in a single session with minimal or no reinforcement at a later time, it is possible that the positive effect of a singleepisode educational intervention on HPV vaccination intention may not be robust enough to affect vaccination behavior among adolescents and young adults who have yet to receive the first dose. On the other hand, enhanced single-session education may increase compliance with completion of the 3-dose series among participants who are given the first dose at the time of the education as demonstrated by Vanderpool et al. [37] . This is worth noting for further exploration since rates of completion of the series understandably lag behind rates of series initiation [7, 16] .
Two recent reviews have included HPV immunization educational interventions in their searches: one focused on parental acceptance of childhood vaccines [22] , and the other included any intervention to increase HPV acceptance [5] . These two reviews include 9 [22] and 7 [5] articles relevant to HPV vaccination education, respectively. The findings of these other reviews are similar to our own in that many of the identified studies were methodologically deficient and results were difficult to generalize [5, 22] .
The most common message-framing dichotomy tested in studies we identified as part of this review was gain-versus loss-framing. None of the nine studies showed significant main effects of gain-/loss-framing. Our negative findings are consistent with a recent metaanalysis which found no significant difference between gain and loss frame messages in persuading people to be vaccinated [59] . Taken together, we can surmise that the relationship between gain-/loss-message frame and HPV vaccine acceptance, if it exists at all, is complex and only relevant under particular circumstances and when moderated by other factors.
Another common framing theme among the identified studies was varying the specifics of HPV disease prevention messages provided to participants, most often between cervical cancer and genital warts prevention messages. Since none of these studies found any difference in vaccination intention between treatment conditions, it is possible that HPV vaccination educational interventions need not focus on one particular aspect of disease prevention to be effective.
One of the major challenges we found with the studies included in this review was the limited generalizability of their findings. Despite the fact that cervical cancer mortality disproportionately affects socioeconomically disadvantaged populations [60], only thirteen (39%) of the studies in this review included populations outside the university setting. Of these, only six tested an intervention that did not require participants to be literate [29, [32] [33] [34] [35] 37 ]. Only one study tested a culturally-tailored intervention in a population at risk for under-immunization (specifically Hispanic Americans), and this study was likely underpowered [32] . Since many of the studies were conducted pre-licensure or in the early years of the HPV vaccine usage in the study country, it was reasonable and appropriate at that time to test educational interventions among anyone eligible to receive or consent for vaccination. However, at this juncture, new research should shift focus to populations at higher risk of disease or under-vaccination.
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One limitation of our review is that our search was restricted to English-language publications. Therefore, the results are difficult to generalize beyond Western European, Australian and North American populations. Furthermore, the vast majority of reviewed studies comparing different message frames for HPV vaccination education were conducted in the U.S. (72%). Given that social norms and beliefs differ by culture, care must be exercised when extrapolating the findings of this review to other populations.
Comparing the studies identified in this review and their conclusions highlighted the potential for bias in different approaches for testing educational interventions. For instance, all four of the parental educational studies that compared within-group attitudes or intentions (from pre-to post-intervention) found a significant improvement [26, [29] [30] [31] . However, none the three that utilized a randomized controlled design found improvement between groups [27,28,32]. When restricted to analyzing within-group data alone, there is no way to determine whether improvement in participant HPV vaccination acceptance may have been partly due to unintended learning about the vaccination from a detailed survey, or to social desirability bias because participants gained a sense of the study's aims. This increases the chances of researchers making the type I error of incorrectly concluding that improvements were the result of the intervention and underscores the importance of the randomized, controlled design for future studies.
Conclusion
Given the association between HPV vaccination acceptance and individual knowledge, attitudes and beliefs, finding effective HPV vaccination educational interventions is essential to reducing HPV-associated morbidity and mortality [9, [61] [62] [63] . Studies to date have largely focused on written informational handouts targeted toward educated populations. Future studies should focus on culturally-competent interventions to reach a more diverse population. Trials should be adequately powered, employ strong research methodology and examine HPV vaccine uptake as the primary outcome.
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